What is Amylyx Pharmaceuticals, Inc.'s debt issuance proceeds?

Amylyx Pharmaceuticals, Inc. (AMLX) reported debt issuance proceeds of $191.11M in Q3 2025.

What does debt issuance proceeds mean?

Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.

Amylyx Pharmaceuticals, Inc. AMLX Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Beam TherapeuticsBEAM

$93.89M—

Sarepta Therapeutics, Inc.SRPT

$250M—

BioCryst PharmaceuticalsBCRX

$400M—

Dyne Therapeutics, Inc.DYN

$49.45M—

Scholar RockSRRK

$1K—

Other financials

Income statement

See full

Revenue-—

Gross profit-—

Operating income-$43.8M-15.8%

Net income-$41.3M-15.0%

EPS (diluted)-$0.37+11.9%

Balance sheet

See full

Cash & equivalents$229.1M+283%

Total debt$5.6M+307%

Total equity$273.2M+35.6%

Total assets$293.6M+33.7%

Cash flow

See full

Operating cash flow-$36.9M+7.4%

CapEx$86.0K+330%

Free cash flow-$28.0M+52.6%

Valuation

See full

Market cap$1.89B+390%

Profitability

See full

Gross margin100%+6.9pp

Operating margin-47,349.8%-47,409pp

Net margin-45,096.2%-45,152pp

FCF margin-39,826.7%-39,847pp

Returns & leverage

See full

Return on equity-63.3%-12.2pp

Debt / equity0×0.0×

Current ratio17.9×+5.8×

Where this comes from

Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromDebtNetOfIssuanceCosts.

The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Amylyx Pharmaceuticals, Inc.'s debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amylyx Pharmaceuticals, Inc.'s debt issuance proceeds?: Amylyx Pharmaceuticals, Inc. (AMLX) reported debt issuance proceeds of $191.11M in Q3 2025.
What does debt issuance proceeds mean?: Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.